Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited is a leading research and development-driven pharmaceutical conglomerate in China. The company operates through a vast network of subsidiaries, most notably Chia Tai-Tianqing (CTTQ) and Beijing Tide Pharmaceutical. It covers the entire industry chain, including R&D, manufacturing, and sales of innovative drugs and high-end generics. The company focuses on several core therapeutic areas including oncology, liver diseases, respiratory diseases, and surgery/analgesia. It is recognized as one of the most innovative pharma companies in Asia, consistently ranking in the top tier of global pharmaceutical companies by R&D investment and market capitalization. It has transitioned significantly from a generics-focused business to an innovation-led powerhouse with a deep pipeline of biologics and small molecules.